Imir G. Metushi, PhD, DABCC, FADLM, is an assistant professor in the Department of Pathology and Laboratory Medicine at the University of California, Los Angeles (UCLA). He serves as Section Chief in Clinical Toxicology/Therapeutic Drug Monitoring and also oversees the UCLA Olympic Analytical Laboratory, which specializes in anti-doping testing. Dr. Metushi is board-certified by the American Board of Clinical Chemistry (DABCC) and hold fellowship status with the Academy of Diagnostics and Laboratory Medicine (FADLM). 

Dr. Metushi earned his doctorate in Pharmacology from the University of Toronto, specializing in immunotoxicology and drug metabolism, and completed his Clinical Chemistry fellowship at the University of California, San Diego. At UCLA, he integrates advanced analytical methods in toxicology, anti-doping testing, point-of-care, and therapeutic drug monitoring (TDM), significantly enhancing laboratory operations across UCLA Health. 

Dr. Metushi has led the incorporation and validation of new tests for TDM, drugs of abuse and novel enzymatic methods for toxic alcohols, expanding the laboratory test menu and improving turnaround times. His research, leveraging technologies such as mass spectrometry, is focused on advancing the detection methods for drugs of abuse and performance-enhancing substance. His work is published in prominent journals, including Clinical Chemistry and has been featured in podcasts underscoring its impact. 

Dedicated to education and mentorship, Dr. Metushi actively guides trainees and early-career clinical scientists through national initiatives such as the UCLA Summer Health Professions Education Program (SHPEP) and international programs like the ADLM Scholars Program.